startups digital health weight loss glp-1 Business Report for Healthtech strategy 5 Startups Looking to Compete

And if you are currently exploring your options, our medically supervised weight loss program uses FDA-approved GLP-1 medications that are available right now, while retatrutide completes its approval process

What people complain about: Some users are unhappy with customer service, claiming a lack of communication between departments

81 It also slows stomach emptying, which helps control appetite and reduce food intake

Long-Term Maintenance Once goals are achieved, we help determine a maintenance strategy that supports sustainable results

The primary endpoint was a change in HbA1c from baseline to 24 weeks, and secondary endpoints included a change in HbA1c and body weight at 36 weeks

Over the past year, companies like Hims & Hers significantly changed the weight loss medication market through aggressive adoption and promotion of compounded GLP-1 agonists